Innovative drugs targeting IDO1 functions in neoplasia

被引：0
|
作者：
Grohmann, U. [1 ]
Macchiarulo, A. [2 ]
机构：
[1] Univ Perugia, Perugia, Italy
[2] Univ Perugia, Dept Pharmaceut Sci, Perugia, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
基金：
欧洲研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2IN
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [31] Alzheimer's and metabolism wed with IDO1
    Johnson, Lance A.
    Macauley, Shannon L.
    SCIENCE, 2024, 385 (6711) : 826 - 827
  • [32] Is IDO1 an adequate target for treatment in glioblastoma?
    Siancas, Christian Andre Marino
    Gonzalez, Ainhoa Hernandez
    Domenech, Marta
    Esteve-Codina, Anna
    Arpi, Oriol
    Alameda, Francesc
    Pineda, Estela
    Chekhun, Sviatoslav
    Paradis, Assumpcio Lopez
    Del Barco, Sonia
    De la Iglesia, Nuria
    Rubio, Oscar Gallego
    Mesia, Carlos
    Mallo, Mar
    Esteve, Anna
    Carrato, Cristina
    Balana, Carmen
    Martinez-Garcia, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Immunological relevance of the coevolution of IDO1 and AHR
    Jaronen, Merja
    Quintana, Francisco J.
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [34] A patent review of IDO1 inhibitors for cancer
    Cheong, Jae Eun
    Ekkati, Anil
    Sun, Lijun
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (04) : 317 - 330
  • [35] IDO1 is an Integral Mediator of Inflammatory Neovascularization
    Mondal, Arpita
    Smith, Courtney
    DuHadaway, James B.
    Sutanto-Ward, Erika
    Prendergast, George C.
    Bravo-Nuevo, Arturo
    Muller, Alexander J.
    EBIOMEDICINE, 2016, 14 : 74 - 82
  • [36] Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer
    Passarelli, Anna
    Pisano, Carmela
    Cecere, Sabrina Chiara
    Di Napoli, Marilena
    Rossetti, Sabrina
    Tambaro, Rosa
    Ventriglia, Jole
    Gherardi, Federica
    Iannacone, Eva
    Venanzio, Sergio Setola
    Fiore, Francesco
    Bartoletti, Michele
    Scognamiglio, Giosue
    Califano, Daniela
    Pignata, Sandro
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] Preclinical in vivo model validation for the development of a novel vaccine based strategy targeting IDO1
    Dey, Souvik
    Sutanto-Ward, Erika
    Mondal, Arpita
    Kopp, Katharina Luise Maria
    Zocca, Mai-Britt
    Pedersen, Ayako Wakatsuki
    Andersen, Mads Hald
    Muller, Alexander J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [38] Displacement Induced Off-On Fluorescent Biosensor Targeting IDO1 Activity in Live Cells
    Jia, Jing
    Wen, Huilin
    Zhao, Sibo
    Wang, Lancheng
    Qiao, Haishi
    Shen, Haowen
    Yu, Ziyi
    Di, Bin
    Xu, Lili
    Hu, Chi
    ANALYTICAL CHEMISTRY, 2019, 91 (23) : 14943 - 14950
  • [39] Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
    Liu, Wuyi
    Zhou, Huyue
    Lai, Wenjing
    Hu, Changpeng
    Wang, Qiaoling
    Yuan, Chengsha
    Luo, Chunmei
    Yang, Mengmeng
    Hu, Min
    Zhang, Rong
    Li, Guobing
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [40] IDO1 in cancer: a Gemini of immune checkpoints
    Lijie Zhai
    Erik Ladomersky
    Alicia Lenzen
    Brenda Nguyen
    Ricky Patel
    Kristen L Lauing
    Meijing Wu
    Derek A Wainwright
    Cellular & Molecular Immunology, 2018, 15 : 447 - 457
12345